Stay updated on SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added entries for Results Posted, More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Document Section under the Study Record History dated 2025-12-23. Removed the 'Results Submitted' entry dated 2025-12-08.
    Difference
    0.5%
    Check dated 2025-12-29T23:05:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page footer, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. This appears to be a routine maintenance update that does not affect trial details or user actions.
    Difference
    0.1%
    Check dated 2025-12-22T22:44:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Version dated 2025-12-08 adds a 'Results Submitted' entry and updates the Study Status; the prior 2025-11-10 entry of 'No Results Posted' was removed.
    Difference
    0.2%
    Check dated 2025-12-08T17:50:08.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T11:43:10.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed from the page header/footer to reflect the latest site revision.
    Difference
    0.0%
    Check dated 2025-11-24T11:38:12.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-11-17T06:16:40.000Z thumbnail image

Stay in the know with updates to SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.